Lipid-Lowering Drugs (Statins) and Peripheral Neuropathy

Electronic Physician
doi 10.19082/6527
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mehr Publishing Group

Related search

Adherence to Lipid Lowering Drugs in Patients With Schizophrenia

Clinical Therapeutics
Pharmacology
2017English

Lipid-Lowering Therapy With Statins May Be Associated With Cataract and Cataract Operation Risks

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Lipid Lowering Drugs and Inflammatory Changes: An Impact on Cardiovascular Outcomes?

Annals of Medicine
Medicine
2018English

Use of Antiepileptic Drugs and Lipid-Lowering Agents in the United States

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2014English

Use of Lipid Lowering Drugs in Primary Care Is Highly Variable

BMJ
1998English

Statins in Peripheral Arterial Disease

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2018English

"Just Make It Lower" Is an Alternative Strategy of Lipid-Lowering Therapy With Statins in Japanese Patients

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Does Lipid Lowering Therapy Improve Calf Muscle Perfusion and Cellular Metabolism in Peripheral Arterial Disease?

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2009English

Pdb5 - Effect of Statins Usage on Incidence of Peripheral Neuropathy Among Patients With Type 2 Diabetes Mellitus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy